Gilead remdesivir study finds only marginal benefit for moderate COVID-19 patients (Reuters) – Moderately ill COVID-19 patients saw their condition improve after a 5-day course of Gilead Sciences Inc’s (GILD.O) […]
The U.S. Food and Drug Administration will review GlaxoSmithKline’s experimental treatment for multiple myeloma, a common form of blood cancer, for a reported side effect which affects the eyes of patients.
Dr. Reddy’s Laboratories’ Foram Vaishnav discusses the role and impact of pharmacovigilance in the pharmaceutical industry.
Johnson & Johnson wins U.S. FDA approval for bladder cancer drug
Advanced bladder cancer, Approvals, Biomarkers, Breakthrough Therapy Designation, FDA, FDA/Regulatory, Fibroblast Growth Factor Receptor (FGFR) Inhibitors, Genetic Mutations, New Drug Application (NDA), Pricing, Priority Review, Shares, Side EffectsJohnson & Johnson’s drug Balversa won U.S. approval as the first targeted therapy for advanced bladder cancer, the Food and Drug Administration announced.
Still no Rx for patient adherence Pharma limited in what it can do, but can still have a positive impact Patient adherence remains a complex puzzle with no simple […]